Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Clinical trial NCT00676507 · COMPLETED

Trial details

NCT number: NCT00676507
Sponsor: NovaRx Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Neoplasm Carcinoma Non-small Cell Lung Cancer Stage IIIA Carcinoma Non-small Cell Lung Cancer Stage IIIB Carcinoma Non-small Cell Lung Cancer Stage IV

Start date: 2008-07-01
Primary completion: 2013-01-01
Enrollment: 532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.